Substituted triazole diamine derivatives as kinase inhibitors

Details Substituted triazole diamine derivatives as kinase inhibitors Substituted triazole diamine derivatives as kinase inhibitors

2005-08-02

2005-08-02

Desai, Rita (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S384000, C548S265200, C548S266200

Reexamination Certificate

active

06924302

ABSTRACT:
The present invention provides substituted triazole diamine derivatives as selective kinase or dual-kinase inhibitors and a method for treating or ameliorating a selective kinase or dual-kinase mediated disorder.

REFERENCES:
patent: 2352944 (1944-07-01), DGaetano
patent: 5674886 (1997-10-01), Okada et al.
patent: 5750545 (1998-05-01), Akahoshi et al.
patent: 1 065 964 (1967-04-01), None
patent: WO 9503286 (1994-07-01), None
patent: WO 9921845 (1999-05-01), None
patent: WO 0109106 (2001-02-01), None
Yakugaku et al., 1997, CAS:88:44882.
PCT international Search Report, dated Jul. 3, 2002 for PCT Appl. No. PCT/US01/50559, which relates to U.S. Appl. No. 10/029,750.
Akahoshi, F., et al., “Synthesis and Pharmacological Activity of Triazolo [1,5-a] triazine Derivatives Inhibiting Eosinophilia,” J. Med. Chem. 1998 41:2985-2993.
Davis, S. T., et al., “Prevention of Chemotherapy-Induced Alopecia in Rats by CDK Inhibitors,” Science 2001 291:134-137.
Dunstan, A. R., et al., “Concise and regiospecific syntheses of tri-substituted 1,2,4-triazoles,” Tetrahedron Letters 1998 39:7983-7986.
Gould, P. L., “Salt selection for basic drugs,” International Journal of Pharma, 1986, 33:201-217.
Hancock, B. C., et al., “Characteristics and Significance of the Amorphous State in Pharmaceutical Systems,” Journal of Pharma Sciences 1997 86(1):1-12.
Jenardanan, G. C., et al., “1-(N-Arylthiocarbamoyl) Amidino-3,5-Dimethyl Pyrazoles-Preparation and Use in Heterocycle Synthesis,” Synthetic Communications 1997 27(19):3457-3462.
McKee, R. L., et al., “p-Substituted Phenyl Isothiocyanates and Some Related Thioureas,” Journal of American Chem Soc 1946 68:2506-2507.
Naito, Y., et al., “Synthesis and Pharmacological Activity of Triazole Derivatives Inhibiting Eosinophilia,” J. Med. Chem 1996 39:3019-3029.
Reiter, J., et al., “On Triazoles. VI[1] The acylation of 5-Amino-1,2,4-triazoles,” J. Heterocyclic Chemistry 1987 24:127-142.
Ross, R., “The pathogenesis of atherosclerosis: a perspective for the 1990's,” Nature 1993 362:801-808.
Webb, R. L., et al., “Diphenyl Cyancarbonimidate and Dichlorodiphenoxymethane as Synthons for the Construction of Heterocyclic Systems of Medicinal Interest,” J Heterocyclic Chemistry1987 24:272-278.
Wei, G.L., et al., “Temporally and Spatially Coordinated Expression of Cell Cycle Regulatory Factors After Angioplasty,” Circ. Res. 1997 80:418-426.
GenBank Accession U93306, Oct. 27, 2000.
Chem Abstract #214, Duvadie, R.K., et. al., “Novel ATP-Site Cyclin-Dependent Kinase”.
Chem Abstract #215, Li, L., et. al., “Novel ATP-Site Cyclin-Dependent Kinase”.

Affiliated with

Also associated with

Rating

Substituted triazole diamine derivatives as kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted triazole diamine derivatives as kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted triazole diamine derivatives as kinase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3467383